[Testis-sparing surgery for benign testicular tumor].

Abstract

OBJECTIVE:

To investigate the safety and feasibility of testis-sparing surgery (TSS) in the treatment of testicular tumor.

METHODS:

We retrospectively analyzed the clinical data of 8 cases of benign testicular tumor treated by TSS in our hospital from October 2005 to March 2012.

RESULTS:

The 8 patients, aged 18-67 (mean 45) years, were preoperatively diagnosed with benign testicular tumor and all underwent partial testis resection. Rapid intraoperative pathology showed the incisal margins to be negative. Postoperative pathological examination confirmed Sertoli cell tumor in 3 cases, adenomatoid tumor in another 3, and mature teratoma in the other 2. The patients were followed up for 6 months to 7 years (mean 4 years), which revealed no relapse and metastasis, nor significant differences from the baseline in the testosterone level, IIEF score, and routine semen parameters.

CONCLUSION:

Testis-sparing surgery is one of the effective options for the management of benign testicular tumor, which can maximally preserve the testis tissue and protect the patient's sexual function.

• Authors: Huang Su, Bian-jiang Liu, Ning-hong Song, Peng-chao Li, Gong Cheng, Jie Yang, Zeng-jun Wang, Li-xin Hua, Chang-jun Yin
• Journal: Zhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 20 Issue 11 Pg. 1020-4 (Nov 2014) ISSN: 1009-3591 [Print] China
• PMID: 25577839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Adolescent
• Adult
• Aged
• Humans
• Male
• Middle Aged
• Neoplasm Recurrence, Local
• Organ Sparing Treatments (methods)
• Retrospective Studies
• Sertoli Cell Tumor (pathology, surgery)
• Teratoma (pathology, surgery)
• Testicular Neoplasms (pathology, surgery)
• Testis